- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05619211
Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities
Improving Cardiorespiratory Fitness and Cardiometabolic Health Among Children With Physical Disabilities Through Movement-to-Music Telehealth With Arm-based Sprint-Intensity Interval Training
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Alabama
-
Homewood, Alabama, United States, 35209
- Wellness Health and Research Facility (WHARF)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
We are recruiting 50 parent-child dyads. Childs are the participant undergoing the exercise intervention. Parents are required to support the safety and schedule of the child participant. Parents are considered participants due to their responsibilities.
Inclusion Criteria:
- have a medical diagnosis of cerebral palsy, as determined by ICD-10 codes
- aged 6-17 years old
- a Gross Motor Function Classification System Level I-IV (as determined via participant screening, explained in the protocol section below)
- medical clearance to participate in high-intensity exercise from a physician (using the attached medical screening form and explained in the intervention safety, monitoring, and response plan)
- access to a Wi-Fi Internet connection in the home via mobile phone or tablet computer
- a caregiver who will support and monitor the participant's safety during the intervention and manage the child's exercise schedule.
Exclusion Criteria:
- physically active (defined as >150 minutes per week of self-reported moderate-to-vigorous intensity exercise in a typical week)
- cannot use their arms for exercise
- a Gross Motor Function Classification Level of V
- complete blindness or deafness;
- Any past history of a contraindication to exercise testing according to American College of Sports Medicine (ACSM) guidelines (Liguori and American College of Sports Medicine, 2020): significant change in the resting electrocardiogram suggesting significant ischemia, myocardial infarction, or other cardiac event, unstable angina, uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise, symptomatic severe aortic stenosis, uncontrolled symptomatic heart failure, pulmonary embolus or pulmonary infarction, myocarditis or pericarditis, aneurysm.
- pregnant (due to radiation from a Dual Energy X-ray Absorptiometry [DEXA] scan)
- has not been seen by a physician within the last year
- uses a g-tube
Eligible caregivers will include parents or legal guardians of the child, who can commit sufficient time to support the child in their roles for the study and communicate in English. Caregivers who have complete blindness or deafness will be excluded from participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Movement-to-Music
12 weeks of sprint-intensity interval training while following along with YouTube videos that include arm-based routines, with coaching through telecommunications.
Participants are instructed to maintain their habitual diet and nutrition patterns
|
Maximal intensity exercises that use the arms.
|
|
No Intervention: Wait-list Control
12 weeks of maintaining habitual physical activity, diet, and nutrition patterns, until receiving 12 weeks of Movement-to-Music
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in pVO2
Time Frame: Week 0, Week 13
|
peak oxygen consumption (mL/kg-1/min-1) obtained from a graded exercise test on an arm ergometer.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Body Weight
Time Frame: Week 0, Week 13
|
body weight in kg measured via DXA scan.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Total Body Fat
Time Frame: Week 0, Week 13
|
body fat in kg measured via DXA scan.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Total Lean Mass
Time Frame: Week 0, Week 13
|
lean mass in kg measured via DXA scan.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Lean Tissue Percentage
Time Frame: Week 0, Week 13
|
percentage of lean tissue per whole body weight.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Fat Tissue Percentage
Time Frame: Week 0, Week 13
|
percentage of fat tissue per whole body weight.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in C-reactive Protein
Time Frame: Week 0, Week 13
|
hsCRP (mg/L) measured via dried blood spot test.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Hemoglobin A1C
Time Frame: Week 0, Week 13
|
HbA1C (mmol/mol) measured via dried blood spot test.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Fasting Insulin
Time Frame: Week 0, Week 13
|
Fasting Insulin (μIU/mL) measured via dried blood spot test.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Fasting Triglycerides
Time Frame: Week 0, Week 13
|
Fasting Triglycerides (mg/dL) measured via dried blood spot test.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Fasting High-density Lipoprotein
Time Frame: Week 0, Week 13
|
HDL cholesterol (mg/dL) measured via dried blood spot test.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Fasting Low-density Lipoprotein
Time Frame: Week 0, Week 13
|
LDL cholesterol (mg/dL) measured via dried blood spot test.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Systolic Blood Pressure
Time Frame: Week 0, Week 13
|
systolic blood pressure (mmHg) measured via blood pressure cuff.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
|
Changes in Diastolic Blood Pressure
Time Frame: Week 0, Week 13
|
diastolic blood pressure (mmHg) measured via blood pressure cuff.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 0, Week 13
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to the Exercise Prescription
Time Frame: Week 1 - 12
|
Percentage of sessions attended versus prescribed.
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 1 - 12
|
|
Number of Participants With Adverse Events
Time Frame: Week 1 - 12
|
Any adverse event reported by participants (e.g., injury).
Data represents the child participant.
Outcome measures were not collected for the parent participant.
|
Week 1 - 12
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300010372
- 1R21HD109358-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Ankara City Hospital BilkentRecruitingCerebral Palsy (CP) | Cerebral Palsy, Spastic, Diplegic | Diplegic Cerebral Palsy With Spasticity | Transcranial Magnetic StimilationTurkey (Türkiye)
-
Lahore University of Biological and Applied SciencesRecruiting
-
Suleyman Demirel UniversityCompletedCerebral Palsy | Hemiplegic Cerebral Palsy | Spastic Diplegia Cerebral PalsyTurkey (Türkiye)
-
Holland Bloorview Kids Rehabilitation HospitalCanadian Institutes of Health Research (CIHR)RecruitingCerebral Palsy (CP) | Hemiplegic Cerebral PalsyCanada
-
Cairo UniversityCompletedCerebral Palsy (CP) | Unilateral Cerebral PalsyEgypt
-
University of California, San FranciscoNot yet recruitingCerebral Palsy | Cerebral Palsy (CP) | Infant | Cerebral Palsy InfantileUnited States
-
Lahore University of Biological and Applied SciencesNot yet recruitingSpastic Diplegia Cerebral PalsyPakistan
-
IRCCS Fondazione Stella MarisNot yet recruitingCerebral Palsy (CP) | EEG | Unilateral Cerebral Palsy | Action ObservationItaly
-
IRCCS Fondazione Stella MarisUniversity of Siena, ItalyRecruitingCerebral Palsy (CP) | Motor Imagery | CP (Cerebral Palsy) | Action ObservationItaly
-
University of LahoreCompletedCerebral Palsy (CP) | Spastic Diplegia Cerebral Palsy | Balance | Gross Motor FunctionsPakistan
Clinical Trials on Sprint-Intensity Interval Training with Telecoaching
-
Riphah International UniversityCompleted
-
McMaster UniversityHamilton Health Sciences CorporationCompletedExercise | Rehabilitation | Spinal Cord InjuriesCanada
-
Foundation University IslamabadRecruitingNon-athletic Active Young AdultsPakistan
-
University of StirlingCompletedMental Health Wellness 1United Kingdom
-
Swinburne University of TechnologyNational Sports Institute of MalaysiaCompletedHealthy | Overweight | Physical InactivityMalaysia
-
University of LeedsUnknownExercise AnaphylaxisUnited Kingdom
-
University of British ColumbiaRecruitingHypertrophy | Muscle Strength | Resistance Training | High-Intensity Interval TrainingCanada
-
Norwegian University of Science and TechnologyCompleted
-
University of WyomingRecruitingAttention Deficit Hyperactivity Disorder | Working Memory | Change in Sustained Attention | Effects of; ExertionUnited States
-
Universiti Tunku Abdul RahmanCompleted